Search results for: 'sales of active hyaluronic'

The U.S. Hyaluronic Acid-Based Biomaterials Market report provides timely information on the Hyaluronic Acid-Based Biomaterials Market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

Biomaterials derived from Hyaluronic Acid (HA) are extensively used in the healthcare industry. Their application ranges from treating osteoarthritis to enabling cataract surgeries to erasing facial wrinkles to preventing post-surgical adhesions. In spite of its wide use, the HA biomaterials market in the United States is not without its worries. ...

This study provides an overview of the global active pharmaceutical ingredients market. It is broadly divided into three chapters- API market analysis, therapeutic-area wise analysis and recommendations to market participants.

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

Telehealth services and systems have made the most progress in remote management of post-acute care patients or among patients with chronic conditions, many of whom have one or more co-morbidity. This progress is visible across 4 major segments: remote patient monitoring (RPM), virtual telehealth visits, mobile health (mHealth), and personal emerge...

06 Jul 2021  |  North America  |  Market Research

Global Decentralized Clinical Trial (DCT) Growth Opportunities

Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum

Infographics

×

Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (CR...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

23 Mar 2021  |  North America  |  Market Research

Innovative Business Models Unleash Growth Opportunities in the MedTech Industry

Unconventional Partnerships Create New Value, Address Evolving Market Needs, and Produce Transformational Growth

Infographics

×

Medical technology (MedTech) firms are on the verge of reinventing their role in enabling care delivery due to various external factors, such as continuous margin pressures from providers on account of increasing healthcare costs, changing needs of end users, rapid technological advancements, empowered patient-consumers taking an active role in the...